Deprince III Daniel DO - 19149 Philadelphia, PA

Business Name: Deprince III Daniel DO
Categorized In: Doctors
Address: 6735 Harbison Avenue, Philadelphia, PA 19149
Phone Number: (215) 725-2000
Contact Person: Daniel Deprince III
Website Address: oxfordrehab.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Castor Family Practice Pllc - Philadelphia, PA 19149
Snipes Edward MD - Philadelphia, PA 19149
Ghantous Victor E MD - Philadelphia, PA 19149
Castor Pediatrics - Philadelphia, PA 19149
Cowen Stephen P DO - Philadelphia, PA 19149
Butta Bart DO - Philadelphia, PA 19149
Sevitski David J DO - Philadelphia, PA 19149
Drexel Cardiology - Philadelphia, PA 19149
Kanevsky Alexander MD - Philadelphia, PA 19149
Blinkoff Barry MD - Philadelphia, PA 19149
Rajaratnam Emma MD - Philadelphia, PA 19149
Vlad Oana MD - Philadelphia, PA 19149
Pomidor Mary MD - Philadelphia, PA 19149
Wood-Harper Deirdre MD - Philadelphia, PA 19149
Joebstl Barbara C MD - Philadelphia, PA 19149
Avart Mark D DO - Philadelphia, PA 19149
Sachs Ira C DO - Philadelphia, PA 19149
Schwartz David S MD - Philadelphia, PA 19149
Temple Geoffrey DO - Philadelphia, PA 19149
Frankil Craig A DO - Philadelphia, PA 19149

Deprince III Daniel DO provides professional Doctors from its single location at the coordinates 40.0397,-75.06516.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 6735 Harbison Avenue, Philadelphia, Pennsylvania 19149 or contacted through representative Daniel Deprince III at (215) 725-2000.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Deprince III Daniel DO through its company website at oxfordrehab.com. Engage with this business on its social media platforms through on Twitter and on Facebook.